))
Is Australia lagging behind in its approach to type 2 diabetes?
Manage episode 492612546 series 2902490
Content provided by Australian Broadcasting Corporation and ABC listen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Australian Broadcasting Corporation and ABC listen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
We might need an update to first-line treatment for type 2 diabetes, according to some experts.
In Australia metformin is the first-line treatment, with drugs called SGLT2 inhibitors considered a second-line approach if needed.
They work by increasing glucose excretion in the urine.
In the United States it’s common to use them as first-line treatment alongside metformin. Is that the right approach?
Guest/s
- Dr Ted Wu, endocrinologist and director of the diabetes centre at the Royal Prince Alfred Hospital in Sydney
50 episodes
Share
